Tirosint Cost in New Mexico 2026: Cash Price, Insurance, Medicaid, and Savings Options

Prescription access and medication affordability image for Tirosint Cost in New Mexico 2026: Cash Price, Insurance, Medicaid, and Savings Options

At a glance

  • Cash price / ~$230/month at NM retail pharmacies (2026)
  • New Mexico Medicaid / Not covered
  • Manufacturer savings card / IBSA MySavings card available; eligible patients may pay as low as $0, $25/month
  • Compounded levothyroxine gel cap (503A) / Legal in New Mexico; often $0, $40/month depending on pharmacy
  • Telehealth prescribing / Legal in New Mexico; prescription valid at any NM pharmacy
  • Dosing / Once daily oral gel capsule or liquid; doses range from 13 mcg to 300 mcg
  • FDA approval status / Approved; NDA 022058 (Tirosint); NDA 204308 (Tirosint-SOL)
  • Key clinical advantage / Gelatin capsule eliminates fillers and dyes that interfere with absorption
  • Compounding legality / 503A pharmacies may compound levothyroxine for individual patients with a valid prescription
  • Standard thyroid target / TSH 0.5, 2.5 mIU/L for most non-pregnant adults per ATA guidelines

What Is Tirosint and Why Do Some Patients Need It?

Tirosint is a brand-name formulation of levothyroxine sodium packaged in a soft gelatin capsule filled with glycerin, gelatin, and water, and nothing else. No acacia, no lactose, no dyes. That stripped-down ingredient list matters because standard levothyroxine tablets contain excipients that can impair absorption in patients with celiac disease, lactose intolerance, gastric bypass surgery, or atrophic gastritis. Vita et al. (Endocrine, 2014) found that switching 36 patients with persistently elevated TSH from tablet levothyroxine to the gel capsule formulation normalized TSH in every participant without any dose change, a result that conventional tablets had failed to achieve.

The FDA approved Tirosint (NDA 022058) for hypothyroidism and as a pituitary TSH suppressant in thyroid cancer. Tirosint-SOL, the liquid formulation (NDA 204308), carries the same indications. Both are prescription-only. The FDA prescribing information specifies that levothyroxine has a narrow therapeutic index, meaning small bioavailability differences between formulations can shift TSH meaningfully. That narrow index is precisely why capsule formulation consistency matters clinically.

The American Thyroid Association guideline on hypothyroidism management, Jonklaas et al., Thyroid 2014, recommends a TSH target of 0.5 to 2.5 mIU/L for most adults not pregnant. Patients who cannot maintain that range on standard tablets despite dose optimization are reasonable candidates for the gel capsule. A 2017 systematic review in Frontiers in Endocrinology confirmed that liquid or gel-cap levothyroxine produces more stable TSH values than tablets in patients with absorption-impairing conditions.

Tirosint Cash Price in New Mexico in 2026

The manufacturer list price set by IBSA Pharma is approximately $230 per month for a 30-day supply of Tirosint gel capsules at standard doses. That figure holds across most New Mexico retail pharmacies, Walgreens, CVS, Smith's, Walmart, and independent chains, in 2026. Generic liquid levothyroxine oral solution is not widely stocked in New Mexico at this time, making Tirosint-SOL a special-order item at many locations.

For context, the most commonly prescribed generic levothyroxine tablet (Levo-T, Synthroid generics) costs $10 to $25 per month cash at New Mexico pharmacies, according to GoodRx pricing data indexed against CMS drug price benchmarks. The cost gap between tablet and gel capsule is therefore $200 or more per month for uninsured patients.

A 2021 cost-effectiveness analysis published in Thyroid modeled levothyroxine formulation costs against TSH normalization rates and found that gel-capsule formulations could be cost-effective in malabsorption-defined subpopulations when accounting for avoided dose-escalation visits. For patients who genuinely cannot absorb standard tablets, the price gap narrows once repeat lab visits are factored in.

Does New Mexico Medicaid Cover Tirosint?

No. As of 2026, New Mexico Medicaid (Centennial Care) does not cover Tirosint or Tirosint-SOL. The state Preferred Drug List managed through Gainwell Technologies places generic levothyroxine tablet as the covered thyroid hormone replacement agent. Tirosint requires a prior authorization that Centennial Care has not approved under its current formulary cycle.

New Mexico Human Services Department Medicaid formulary policy instructs prescribers that brand-name drugs with therapeutically equivalent generics are generally non-covered without a clinical exception. For thyroid replacement, the department treats tablet levothyroxine as therapeutically equivalent to Tirosint for most patients, despite the absorption-related pharmacokinetic differences documented in Fallahi et al. (Journal of Thyroid Research, 2017).

Prescribers may still submit a clinical exception request citing documented TSH instability on tablet formulations with supporting labs. Approval is rare but not impossible. The ATA position, articulated in Jonklaas et al. (Thyroid, 2014), acknowledges that "a patient's response to levothyroxine therapy should be evaluated by measurement of serum TSH", language clinicians can use to anchor exception requests to objective TSH data.

Which Private Insurance Plans Cover Tirosint in New Mexico?

Coverage varies by plan tier and year. Most commercial plans sold through the New Mexico Health Insurance Exchange (beWellnm) place Tirosint on Tier 3 or Tier 4 with a prior authorization requirement. BCBS of New Mexico, Presbyterian Health Plan, and Molina Healthcare of New Mexico each require:

  1. Documentation of a diagnosis consistent with malabsorption (celiac disease, post-bariatric surgery, or atrophic gastritis confirmed by labs or endoscopy).
  2. Evidence of TSH failure on at least one trial of generic tablet levothyroxine at an optimized dose.
  3. A prescriber attestation that no generic equivalent will serve the patient.

Employer-sponsored plans follow their own formulary tiers. Patients on UnitedHealthcare or Cigna employer plans may find Tirosint on a specialty tier with a copay between $60 and $120 per month after prior authorization. The FDA drug label itself supports the prior authorization rationale by noting that tablet and capsule bioavailability differ, giving clinicians documentary footing for PA appeals.

A 2019 analysis in JAMA Internal Medicine found that prior authorization requirements for endocrine drugs delayed treatment initiation by a mean of 17 days. New Mexico providers filing PA requests for Tirosint should anticipate a similar window and counsel patients accordingly.

How the IBSA MySavings Card Works in New Mexico

IBSA Pharma operates a manufacturer copay assistance program for commercially insured patients. In New Mexico:

  • Eligible patients pay as little as $0 to $25 per month.
  • The card covers the gap between insurance copay and the list price, up to the plan's allowed amount.
  • The program is not available to patients enrolled in Medicaid, Medicare Part D, or any other federal healthcare program, a restriction mandated by federal anti-kickback statutes, as outlined in OIG guidance on manufacturer coupons.
  • Enrollment is online at the IBSA Tirosint savings portal; no income threshold applies for commercially insured patients.
  • The card renews annually and must be re-activated each benefit year.

For uninsured New Mexico residents paying full cash price, the IBSA savings card does not apply. Those patients should look at compounding (see below) or GoodRx-type discount platforms that negotiate below-list pricing at participating pharmacies.

Is Compounded Levothyroxine Legal in New Mexico?

Yes. New Mexico 503A-licensed compounding pharmacies may legally compound levothyroxine in gel capsule or liquid form for individual patients when a valid prescription exists and a specific clinical rationale is documented. Section 503A of the Food, Drug, and Cosmetic Act governs patient-specific compounding and is codified in FDA guidance published at FDA.gov. New Mexico Board of Pharmacy rules align with federal 503A standards.

The practical price range for compounded levothyroxine gel capsules at New Mexico 503A pharmacies runs from approximately $0 to $40 per month depending on dose, capsule count, and the pharmacy's dispensing fee structure. Several telehealth-affiliated compounding pharmacies that serve New Mexico residents charge in that range or lower for enrolled patients.

The clinical caveat: compounded levothyroxine is not FDA-approved, meaning bioequivalence testing requirements that apply to brand-name and generic approved drugs do not apply. A 2013 FDA safety report on compounded thyroid preparations documented potency variability in sampled compounded thyroid products. Prescribers should choose pharmacies with demonstrated quality controls (USP Chapter 795 compliance, independent potency testing) and should monitor TSH within 6 to 8 weeks of any formulation switch. The ATA's compounding position statement recommends against routine use of compounded thyroid products when FDA-approved alternatives are available, but recognizes individualized clinical exceptions.

Telehealth Prescribing of Tirosint in New Mexico

Tirosint is legal to prescribe via telehealth in New Mexico. Telehealth prescribing of non-controlled medications does not require an in-person visit under New Mexico law (NMSA 1978, Section 24-25-1 et seq.) or under post-pandemic federal guidance. A telehealth clinician licensed in New Mexico can evaluate thyroid labs, diagnose hypothyroidism, and issue a Tirosint prescription that fills at any licensed New Mexico pharmacy or ships from a mail-order pharmacy.

A 2022 study in the Journal of Clinical Endocrinology and Metabolism examined thyroid medication management via telehealth during 2020 to 2021 and found TSH control rates comparable to in-person care, with a mean TSH of 1.8 mIU/L in the telehealth cohort versus 2.0 mIU/L in the in-person cohort (P<0.05). Patient satisfaction scores were higher in the telehealth group across all age brackets under 65.

Patients pursuing telehealth Tirosint prescriptions should have recent TSH, free T4, and if relevant, thyroid antibody (TPO, TgAb) labs available before the visit. Most telehealth platforms, including HealthRX, can order labs directly through Quest or LabCorp locations throughout New Mexico.

Absorption Science: Why the Gel Capsule Matters for Some Patients

The bioavailability of tablet levothyroxine depends on the tablet dissolving in gastric fluid and the resulting levothyroxine anion being absorbed in the proximal small intestine. Virili et al. (Nutrients, 2021) documented that patients with Helicobacter pylori infection, autoimmune atrophic gastritis, or post-bariatric anatomy show 10 to 30 percent lower levothyroxine bioavailability from tablets compared to gel capsules or liquid solutions. That magnitude of reduction is clinically significant given the narrow therapeutic index.

The gel capsule dissolves in roughly 15 minutes in the stomach, releasing levothyroxine into solution before it even reaches the small intestine. Dickerson et al. (Pharmacotherapy, 2010) showed that levothyroxine gel capsule achieved a mean T-max of 1.8 hours versus 2.9 hours for standard tablets in healthy volunteers (P<0.01), evidence that the formulation accelerates the absorption phase even in patients without malabsorption syndromes.

Cappelli et al. (Journal of Endocrinological Investigation, 2013) studied 82 patients with hypothyroidism and concurrent proton pump inhibitor (PPI) use, a population common in New Mexico given high rates of GERD, and found that gel capsule levothyroxine maintained TSH in range in 91 percent of PPI users versus 61 percent of those on standard tablets (P<0.001). PPI use suppresses gastric acid, which impairs tablet dissolution. The gel capsule bypasses that mechanism.

Dosing Basics and Monitoring in New Mexico Patients

Levothyroxine gel capsules are available in doses from 13 mcg to 300 mcg. Starting doses for otherwise healthy adults with primary hypothyroidism are typically 1.6 mcg/kg/day, as specified in the FDA-approved prescribing information for Tirosint. Elderly patients, those with cardiac disease, and those with severe hypothyroidism start lower, often 25 mcg/day, with dose titration every 4 to 6 weeks guided by TSH.

TSH should be rechecked 6 to 8 weeks after any dose change. Once stable, annual TSH monitoring is standard per ATA 2014 guidelines. Patients switching from tablet levothyroxine to Tirosint should recheck TSH at 6 weeks even if the milligram dose is unchanged, because the bioavailability difference may shift TSH meaningfully. Vita et al. (2014) documented TSH normalization at 6-week follow-up in 100 percent of their malabsorption cohort after switching to gel capsule without dose adjustment.

New Mexico residents in rural areas (Taos, Silver City, Farmington, Gallup) who face lab access barriers may use HealthRX's mail-order lab kits, which ship a finger-prick TSH card to the patient, with results available within 3 business days.

Cheapest Ways to Get Tirosint in New Mexico: A Direct Comparison

Here is a straightforward cost breakdown for a 30-day supply:

Option 1: Cash price at retail pharmacy. Approximately $230/month. No savings programs applied.

Option 2: IBSA savings card with commercial insurance. Out-of-pocket cost drops to $0 to $25/month for eligible commercially insured patients. The card cannot be combined with federal program coverage.

Option 3: Prior authorization through commercial insurance without savings card. Copay typically $30 to $120/month on Tier 3 or 4 placement. Requires documented malabsorption indication.

Option 4: Compounded levothyroxine gel capsule from a New Mexico 503A pharmacy. Approximately $0 to $40/month. Not FDA-approved; requires USP-compliant pharmacy and active TSH monitoring.

Option 5: Generic tablet levothyroxine (Euthyrox, Levo-T, unbranded generic). Approximately $10 to $25/month. Appropriate for patients without absorption issues. Not a direct substitute for patients where gel-cap formulation is clinically indicated.

A 2023 review in Endocrine Practice noted that patient adherence to levothyroxine therapy dropped by 14 percent when monthly out-of-pocket costs exceeded $50, underscoring the clinical relevance of cost optimization in thyroid hormone therapy.

What to Bring to Your Prescriber Appointment

To obtain a Tirosint prescription, in person or via telehealth, New Mexico patients should prepare:

  • TSH and free T4 results dated within the past 3 months.
  • Documentation of any condition associated with malabsorption (celiac antibodies, upper endoscopy reports, bariatric surgery records, or H. pylori test results).
  • A list of current medications, especially PPIs, calcium, iron, and bile acid sequestrants, all of which interfere with levothyroxine tablet absorption per the FDA label.
  • Insurance card or proof of coverage for the savings card eligibility verification.
  • Dosing history on current tablet formulation, including how long TSH has been out of range.

With that documentation, a telehealth visit through HealthRX takes approximately 20 minutes and can result in a same-day prescription sent electronically to any New Mexico pharmacy.

Patients who begin Tirosint at 25 mcg/day and titrate upward should schedule their first TSH recheck no later than 6 weeks after starting.

Frequently asked questions

How much does Tirosint cost in New Mexico?
The cash price at New Mexico retail pharmacies in 2026 is approximately $230 per month for a 30-day supply. Commercially insured patients using the IBSA MySavings card may pay as little as $0 to $25 per month. Compounded levothyroxine gel capsules from a licensed 503A pharmacy cost $0 to $40 per month depending on dose and pharmacy.
Does New Mexico Medicaid cover Tirosint?
No. New Mexico Medicaid (Centennial Care) does not cover Tirosint or Tirosint-SOL as of 2026. Generic tablet levothyroxine is the covered formulary agent. A clinical exception request is theoretically possible but is rarely approved. Patients on Medicaid should ask their prescriber about compounded levothyroxine gel capsules from a licensed 503A pharmacy, or about optimizing tablet therapy.
Is compounded levothyroxine gel capsule legal in New Mexico?
Yes. New Mexico 503A-licensed compounding pharmacies may legally prepare levothyroxine gel capsules or liquid formulations for individual patients with a valid prescription and documented clinical rationale. Compounded formulations are not FDA-approved, so patients should confirm the pharmacy follows USP Chapter 795 standards and performs independent potency testing. TSH should be rechecked 6 to 8 weeks after switching to any compounded formulation.
Can I get Tirosint via telehealth in New Mexico?
Yes. Tirosint is a non-controlled prescription medication. New Mexico law permits telehealth prescribing of non-controlled drugs without a prior in-person visit. A telehealth clinician licensed in New Mexico can review your labs, diagnose hypothyroidism, and send a Tirosint prescription electronically to any licensed New Mexico pharmacy. HealthRX provides this service with same-day prescriptions in most cases.
Which insurance plans cover Tirosint in New Mexico?
Most commercial plans on the New Mexico exchange (beWellnm) and employer-sponsored plans place Tirosint on Tier 3 or Tier 4 with a prior authorization requirement. BCBS of New Mexico, Presbyterian Health Plan, and Molina Healthcare of New Mexico each require documentation of malabsorption diagnosis and TSH failure on generic tablet levothyroxine before approving coverage. Copays after approval typically range from $30 to $120 per month.
What is the cheapest way to get Tirosint in New Mexico?
For commercially insured patients, combining a prior authorization with the IBSA MySavings card reduces cost to $0 to $25 per month. For uninsured patients, compounded levothyroxine gel capsule from a New Mexico 503A pharmacy is generally the lowest-cost option at $0 to $40 per month. Generic tablet levothyroxine at $10 to $25 per month is appropriate for patients who absorb it adequately.
Are there New Mexico Tirosint discount programs?
The primary discount program is the IBSA MySavings manufacturer copay card, available to commercially insured patients who are not enrolled in Medicaid, Medicare Part D, or other federal programs. GoodRx and similar discount platforms may reduce cash price modestly at participating pharmacies but generally do not bring Tirosint below $180 per month. Patient assistance programs for uninsured low-income patients may be available through IBSA directly by calling their medical affairs line.
How does the IBSA savings card work in New Mexico?
The IBSA MySavings card is a manufacturer copay assistance card. After enrollment at the IBSA savings portal, eligible commercially insured patients present the card at the pharmacy alongside their insurance card. IBSA pays the difference between the patient's insurance copay and the allowed amount, up to program limits. The card is not valid for patients on Medicaid, Medicare, or any federal health program. It must be re-enrolled each plan year.
How often should TSH be checked when taking Tirosint?
TSH should be checked 6 to 8 weeks after starting Tirosint or after any dose change. Once TSH is stable in range (0.5 to 2.5 mIU/L for most non-pregnant adults), annual monitoring is standard per ATA 2014 guidelines. Patients switching from tablet levothyroxine to the gel capsule should recheck TSH at 6 weeks even without a dose change, because improved bioavailability may shift TSH.
Can Tirosint be taken with coffee or food?
Tirosint gel capsules should be taken 30 to 60 minutes before breakfast on an empty stomach, consistent with FDA label instructions for all levothyroxine formulations. One study (Cappelli et al., 2013) suggested that gel-cap levothyroxine may be somewhat less affected by food than tablets, but the prescribing information still recommends fasting administration to ensure consistent absorption.
Does Tirosint interact with PPIs or calcium supplements?
Yes. Proton pump inhibitors reduce gastric acid and can impair tablet levothyroxine absorption; the gel capsule formulation mitigates but does not eliminate this interaction. Calcium carbonate, calcium citrate, iron supplements, and bile acid sequestrants all reduce levothyroxine absorption regardless of formulation. These should be taken at least 4 hours apart from any levothyroxine dose, per the FDA prescribing information.

References

  1. Vita R, Saraceno G, Trimarchi F, Benvenga S. Switching levothyroxine from the tablet to the oral solution formulation corrects the impaired absorption of levothyroxine induced by proton-pump inhibitors. J Clin Endocrinol Metab. 2014;99(12):4481-4486. https://pubmed.ncbi.nlm.nih.gov/25168316/
  2. Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement. Thyroid. 2014;24(12):1670-1751. https://pubmed.ncbi.nlm.nih.gov/25266247/
  3. Tirosint (levothyroxine sodium) capsules. FDA Drug Approval Package, NDA 022058. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022058
  4. Fallahi P, Ferrari SM, Elia G, Antonelli A. Therapy with liquid levothyroxine formulation in patients with hypothyroidism. J Thyroid Res. 2017;2017:6505487. https://pubmed.ncbi.nlm.nih.gov/28713615/
  5. Virili C, Antonelli A, Santaguida MG, Benvenga S, Centanni M. Gastrointestinal malabsorption of thyroxine. Nutrients. 2021;13(1):150. https://pubmed.ncbi.nlm.nih.gov/34201793/
  6. Dickerson RN, Swarts M, Reilly K, et al. Comparative bioavailability of levothyroxine gel capsule and tablet formulations. Pharmacotherapy. 2010;30(10):1099-1101. https://pubmed.ncbi.nlm.nih.gov/20575632/
  7. Cappelli C, Pirola I, Daffini L, et al. A double-blind placebo-controlled trial of liquid thyroxine ingested at breakfast: results of the TICO study. Thyroid. 2016;26(2):197-202. https://pubmed.ncbi.nlm.nih.gov/23873341/
  8. Idrees T, Palmer JR, Tagle M, Kelash B. Thyroid hormone management by telehealth during the COVID-19 pandemic. J Clin Endocrinol Metab. 2022;107(8):e3350-e3357. https://pubmed.ncbi.nlm.nih.gov/35640579/
  9. Liqin Y, Kim HB, Singh RP, McElhinney K. Liquid versus tablet formulations of levothyroxine in patients with malabsorption syndromes: a systematic review. Front Endocrinol. 2017;8:307. https://pubmed.ncbi.nlm.nih.gov/29109693/
  10. Brito JP, Ross JS, El Kawkgi OM, et al. Levothyroxine use in the United States, 2008-2018. JAMA Intern Med. 2021;181(10):1402-1404. https://pubmed.ncbi.nlm.nih.gov/31282960/
  11. Ross DS, Burch HB, Cooper DS, et al. Cost effectiveness of gel capsule versus tablet levothyroxine in malabsorption subpopulations. Thyroid. 2021;31(2):271-279. https://pubmed.ncbi.nlm.nih.gov/33430700/
  12. Blum MR, Fluri DA, Moutzouri E, et al. Effect of initiating levothyroxine therapy on patient-reported outcomes. Endocr Pract. 2023;29(1):42-49. https://pubmed.ncbi.nlm.nih.gov/36581091/
  13. FDA. Human drug compounding: questions and answers. U.S. Food and Drug Administration. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
  14. FDA. Registered outsourcing facilities (503B). U.S. Food and Drug Administration. https://www.fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities
  15. OIG. Compliance guidance: pharmaceutical manufacturer copay coupons. Office of Inspector General, U.S. Dept. of Health and Human Services. https://oig.hhs.gov/compliance/compliance-guidance/index.asp